Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
Sep 14, 2025, 3:49 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 47.32 million as of September 12, 2025. Its market cap has decreased by -13.76% in one year.
Market Cap
47.32M
Enterprise Value
25.87M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 47.32M, an increase of 195.04%. That is a compound annual growth rate of 5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2025 | 47.32M | -16.52% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | 92.29M | 106.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 75.88B |
| Danel (Adir Yeoshua) | 2.89B |
| Kamada | 1.36B |
| BrainsWay | 990.45M |
| SofWave Medical | 980.61M |
| Bait Bakfar | 979.07M |
| Novolog (Pharm-Up 1966) | 757.12M |
| Ilex Medical | 708.32M |